We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Software Developed to Accelerate Genome Research

By Biotechdaily staff writers
Posted on 24 Apr 2008
A U.S. More...
research team has developed software that can analyze half a million DNA sequences in 10 minutes.

The Marth laboratory's (Boston College [BC]; Chestnut Hill, MA, USA) proprietary PyroBayes software is one of a new type of computer programs able to accurately process the mountains of genome data flowing from the latest generation of gene decoding machines, which have placed a premium on computational speed and accuracy in data-compiling fields known as bioinformatics and high-throughput biology, according to Dr. Gabor Marth, an associate professor of biology at BC.

"We're on the edge of a real technological revolution that I think will help us understand the genetic causes of diseases in humans and how genetic materials determine traits in animals,” said Dr. Marth. "It is going to lead to less expensive technologies that will allow researchers to decode any individual.”

The PyroBayes software will aid researchers involved in the 1000 Genomes Project, which recently announced a plan to sequence the genomes of 1000 individuals from around the world. The U.S. National Institutes of Health (NIH; Bethesda, MD, USA), which helps direct the project, has awarded Dr. Marth more than US$1.3 million to develop the software over the next four years.

The advances of the Marth lab were revealed in two articles published by the professor and his assistants in the February 2008 issue of the journal Nature Methods. In an article co-authored by Dr. Marth, post-doctoral researcher Dr. Chip Stewart, and graduate students Aaron Quinlan and Mike Strömberg, the group unveiled the lab's PyroBayes base caller software, which examines data from one of the latest generation of DNA decoding machines--developed by Roche/454 Life Sciences (Branford, CT, USA)--faster and with far greater accuracy than other programs for pyrosequencing, a technology that utilizes the detection of pyrophosphate for decoding the sequence of DNA, the carrier of genetic information in living organisms.

A second Nature Methods article in the same issue, written in collaboration with colleagues from the Washington University School of Medicine (St. Louis, MO, USA), reported that three other computer programs developed by the Marth lab made it possible to rapidly and effectively study the whole genome of a laboratory worm and identify key differences between the sample strain and an earlier strain--a comparative process known as resequencing, now being applied to the genomes of humans and other organisms. This second study used another next-generation DNA sequencing platform, the Illumina/Solexa machine.

Recent developments are driving resequencing costs down, but researchers must still prove the effectiveness of the new technology by working with smaller organisms, which made the worm study critical, Dr. Marth reported. "This brings us closer to a major milestone in human individual resequencing--the decoding of the genome of human beings in routine fashion.”

Of the few computer programs available for the new sequencing machines, the software package developed by the Marth lab is the only one capable of working with a variety of decoding machines and offers greater accuracy, allowing researchers to separate accurate genetic variations from data errors, according to Dr. Marth. PyroBayes, a Linux-based package, is made available to fellow academic researchers at no cost.

Marth lab, as an analysis group member, participates in the analysis of the 1000 Genomes Project data, which was launched in February 2008. The goal of the project is to sequence the genomes of at least 1000 people worldwide to create the most detailed and medically useful picture to date of human genetic variation.

Ultimately, advances in bioinformatics will help push genetic science forward, providing new insights on human health and disease, according to Dr. Marth. He envisions his lab's role in providing critical tools that help researchers to organize and interpret data, and visualize genome variations.

"We are excited to develop the software that will help these super-fast, high-throughput sequencing machines to realize their potential to produce invaluable data for research,” Dr. Marth said.


Related Links:
Marth Laboratory of Boston College

Gold Member
Hybrid Pipette
SWITCH
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
HBV DNA Test
GENERIC HBV VIRAL LOAD VER 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.